AHR Function in Lymphocytes: Emerging Concepts

Trends in Immunology

Volumn 37, Issue 1, 2016, Pages 17-31

  Zhou, Liang ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; LIGAND;

ADAPTIVE IMMUNITY; CELL SPECIFICITY; CONCEPTUAL FRAMEWORK; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; HUMAN VERSUS ANIMAL COMPARISON; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOCYTE DIFFERENTIATION; MICROENVIRONMENT; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL; TH22 CELL; TISSUE SPECIFICITY; ANIMAL; ANTIBODY SPECIFICITY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; TUMOR MICROENVIRONMENT;

ADAPTIVE IMMUNITY; ANIMALS; CELLULAR MICROENVIRONMENT; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; LYMPHOCYTES; ORGAN SPECIFICITY; RECEPTORS, ARYL HYDROCARBON;

EID: 84952864852     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2015.11.007     Document Type: Review

References (129)

1. Ema M., et al. cDNA cloning and structure of mouse putative Ah receptor. Biochem. Biophys. Res. Commun. 1992, 184:246-253.
2. Burbach K.M., et al. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:8185-8189.
3. Itoh S., et al. Human Ah receptor cDNA: analysis for highly conserved sequences. Nucleic Acids Res. 1993, 21:3578.
4. Dolwick K.M., et al. Cloning and expression of a human Ah receptor cDNA. Mol. Pharmacol. 1993, 44:911-917.
5. Hankinson O. The aryl hydrocarbon receptor complex. Annu. Rev. Pharmacol. Toxicol. 1995, 35:307-340.
6. Lee J.S., et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 2012, 13:144-151.
7. Li Y., et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011, 147:629-640.
8. Zelante T., et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 2013, 39:372-385.
9. Esser C., Rannug A. The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology. Pharmacol. Rev. 2015, 67:259-279.
10. Julliard W., et al. The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both. Front. Immunol. 2014, 5:458.
11. Stockinger B., et al. The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 2014, 32:403-432.
12. Gu Y.Z., et al. The PAS superfamily: sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 2000, 40:519-561.
13. Wang G.L., Semenza G.L. Purification and characterization of hypoxia-inducible factor 1. J. Biol. Chem. 1995, 270:1230-1237.
14. Stevens E.A., et al. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 2009, 127:299-311.
15. Wu D., et al. Structure and dimerization properties of the aryl hydrocarbon receptor PAS-A domain. Mol. Cell. Biol. 2013, 33:4346-4356.
16. Esser C., et al. The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009, 30:447-454.
17. Nguyen L.P., Bradfield C.A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 2008, 21:102-116.
18. McGuire J., et al. Definition of a dioxin receptor mutant that is a constitutive activator of transcription: delineation of overlapping repression and ligand binding functions within the PAS domain. J. Biol. Chem. 2001, 276:41841-41849.
19. Andersson P., et al. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:9990-9995.
20. Nohara K., et al. Constitutively active aryl hydrocarbon receptor expressed specifically in T-lineage cells causes thymus involution and suppresses the immunization-induced increase in splenocytes. J. Immunol. 2005, 174:2770-2777.
21. Duarte J.H., et al. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo. PLoS ONE 2013, 8:e79819.
22. Kimura A., et al. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9721-9726.
23. Quintana F.J., et al. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
24. Veldhoen M., et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
25. Simonian P.L., et al. gammadelta T cells protect against lung fibrosis via IL-22. J. Exp. Med. 2010, 207:2239-2253.
26. Ebihara T., et al. Runx3 specifies lineage commitment of innate lymphoid cells. Nat. Immunol. 2015, 16:1124-1133.
27. Mezrich J.D., et al. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J. Immunol. 2010, 185:3190-3198.
28. Kimura A., et al. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J. Exp. Med. 2009, 206:2027-2035.
29. Nguyen N.T., et al. Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19961-19966.
30. Quintana F.J., et al. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20768-20773.
31. Zhou L., et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8:967-974.
32. Yang X.O., et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J. Biol. Chem. 2007, 282:9358-9363.
33. Durant L., et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 2010, 32:605-615.
34. Guo X., et al. Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 2014, 40:25-39.
35. Wong L.Y., et al. Ikaros sets the potential for Th17 lineage gene expression through effects on chromatin state in early T cell development. J. Biol. Chem. 2013, 288:35170-35179.
36. Heller J.J., et al. Restriction of IL-22-producing T cell responses and differential regulation of regulatory T cell compartments by zinc finger transcription factor Ikaros. J. Immunol. 2014, 193:3934-3946.
37. Zeng H., Chi H. Metabolic control of regulatory T cell development and function. Trends Immunol. 2015, 36:3-12.
38. Jacobs H., et al. Retinoic acid drives aryl hydrocarbon receptor expression and is instrumental to dioxin-induced toxicity during palate development. Environ. Health Perspect. 2011, 119:1590-1595.
39. Takami M., et al. Cutting edge: AhR is a molecular target of calcitriol in human t cells. J. Immunol. 2015, 195:2520-2523.
40. Kazlauskas A., et al. The immunophilin-like protein XAP2 regulates ubiquitination and subcellular localization of the dioxin receptor. J. Biol. Chem. 2000, 275:41317-41324.
41. Lees M.J., et al. Defining the role for XAP2 in stabilization of the dioxin receptor. J. Biol. Chem. 2003, 278:35878-35888.
42. Morales J.L., Perdew G.H. Carboxyl terminus of hsc70-interacting protein (CHIP) can remodel mature aryl hydrocarbon receptor (AhR) complexes and mediate ubiquitination of both the AhR and the 90 kDa heat-shock protein (hsp90) in vitro. Biochemistry 2007, 46:610-621.
43. Mimura J., et al. Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev. 1999, 13:20-25.
44. Evans B.R., et al. Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator. Mol. Pharmacol. 2008, 73:387-398.
45. MacPherson L., et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADP-ribosyltransferase and repressor of aryl hydrocarbon receptor transactivation. Nucleic Acids Res. 2013, 41:1604-1621.
46. MacPherson L., et al. Aryl hydrocarbon receptor repressor and TiPARP (ARTD14) use similar, but also distinct mechanisms to repress aryl hydrocarbon receptor signaling. Int. J. Mol. Sci. 2014, 15:7939-7957.
47. Ma Q., et al. TCDD-inducible poly(ADP-ribose) polymerase: a novel response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Biophy. Res. Commun. 2001, 289:499-506.
48. Qiu J., et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 2012, 36:92-104.
49. Cui G., et al. Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation. J. Clin. Invest. 2011, 121:658-670.
50. Kee B.L. E and ID proteins branch out. Nat. Rev. Immunol. 2009, 9:175-184.
51. Guo X., et al. Innate lymphoid cells control early colonization resistance against intestinal pathogens through ID2-dependent regulation of the microbiota. Immunity 2015, 42:731-743.
52. Kerkvliet N.I. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int. Immunopharmacol. 2002, 2:277-291.
53. Marshall N.B., Kerkvliet N.I. Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells. Ann. N. Y. Acad. Sci. 2010, 1183:25-37.
54. Rannug A., et al. Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J. Biol. Chem. 1987, 262:15422-15427.
55. Shertzer H.G., Senft A.P. The micronutrient indole-3-carbinol: implications for disease and chemoprevention. Drug Metab. Drug Interact. 2000, 17:159-188.
56. Kiss E.A., et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334:1561-1565.
57. Jux B., et al. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J. Immunol. 2009, 182:6709-6717.
58. Vogel C.F., et al. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem. Biophys. Res. Commun. 2008, 375:331-335.
59. Magiatis P., et al. Malassezia yeasts produce a collection of exceptionally potent activators of the Ah (dioxin) receptor detected in diseased human skin. J. Invest. Dermatol. 2013, 133:2023-2030.
60. Moura-Alves P., et al. AhR sensing of bacterial pigments regulates antibacterial defence. Nature 2014, 512:387-392.
61. Di Meglio P., et al. Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions. Immunity 2014, 40:989-1001.
62. Feuerer M., et al. Genomic definition of multiple ex vivo regulatory T cell subphenotypes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:5919-5924.
63. + T helper cells. Cell 2006, 126:1121-1133.
64. Korn T., et al. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
65. Wang X., et al. Transcription of Il17 and Il17f is controlled by conserved noncoding sequence 2. Immunity 2012, 36:23-31.
66. Laurence A., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
67. Liao W., et al. Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages. Nat. Immunol. 2011, 12:551-559.
68. Yang X.P., et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 2011, 12:247-254.
69. + regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 2011, 34:409-421.
70. + regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 2011, 34:422-434.
71. Quintana F.J., et al. Aiolos promotes T(H)17 differentiation by directly silencing Il2 expression. Nat. Immunol. 2012, 13:770-777.
72. Veldhoen M., et al. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 2009, 206:43-49.
73. McGeachy M.J., et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 2007, 8:1390-1397.
74. Lee Y., et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 2012, 13:991-999.
75. Ouyang W., et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29:71-109.
76. Rutz S., et al. IL-22, not simply a Th17 cytokine. Immunol. Rev. 2013, 252:116-132.
77. Rutz S., et al. Transcription factor c-Maf mediates the TGF-beta-dependent suppression of IL-22 production in T(H)17 cells. Nat. Immunol. 2011, 12:1238-1245.
78. Basu R., et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity 2012, 37:1061-1075.
79. + T cells. Nat. Commun. 2014, 5:3753.
80. Veldhoen M., et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
81. Mangan P.R., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006, 441:231-234.
82. Bettelli E., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
83. + group 3 ILCs and controls intestinal immunity and inflammation. Semin. Immunopathol. 2013, 35:657-670.
84. Yang X.O., et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity 2008, 28:29-39.
85. Yoshida T., Georgopoulos K. Ikaros fingers on lymphocyte differentiation. Int. J. Hematol. 2014, 100:220-229.
86. Hill J.A., et al. Foxp3 transcription-factor-dependent and -independent regulation of the regulatory T cell transcriptional signature. Immunity 2007, 27:786-800.
87. Joller N., et al. Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responses. Immunity 2014, 40:569-581.
88. Nguyen N.T., et al. The roles of aryl hydrocarbon receptor in immune responses. Int. Immunol. 2013, 25:335-343.
89. Benson J.M., Shepherd D.M. Aryl hydrocarbon receptor activation by TCDD reduces inflammation associated with Crohn's disease. Toxicol. Sci. 2011, 120:68-78.
90. + regulatory T cells. Nat. Immunol. 2010, 11:846-853.
91. Singh N.P., et al. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS ONE 2011, 6:e23522.
92. Opitz C.A., et al. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011, 478:197-203.
93. Bessede A., et al. Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 2014, 511:184-190.
94. Monteleone I., et al. Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract. Gastroenterology 2011, 141:237-248.
95. Qiu J., et al. Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. Immunity 2013, 39:386-399.
96. Zhou L., et al. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008, 453:236-240.
97. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat. Rev. Immunol. 2010, 10:170-181.
98. + T cell lineage differentiation. Immunity 2009, 30:646-655.
99. Awasthi A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 2007, 8:1380-1389.
100. Fitzgerald D.C., et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 2007, 8:1372-1379.
101. Stumhofer J.S., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 2007, 8:1363-1371.
102. Apetoh L., et al. The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27. Nat. Immunol. 2010, 11:854-861.
103. Gagliani N., et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 2015, 523:221-225.
104. Mascanfroni I.D., et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat. Med. 2015, 21:638-646.
105. + lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011, 34:122-134.
106. + ILC3s in models of intestinal inflammation. J. Exp. Med. 2015, 212:1869-1882.
107. + T-cell responses to intestinal commensal bacteria. Nature 2013, 498:113-117.
108. + T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014, 41:283-295.
109. + Th2 cell responses. J. Immunol. 2014, 192:2442-2448.
110. + T cells regulate IL-22-producing intestinal innate lymphoid cells. Mucosal Immunol. 2014, 7:1045-1057.
111. von Burg N., et al. Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:12835-12840.
112. + T cells. Science 2015, 348:1031-1035.
113. Wagage S., et al. The group 3 innate lymphoid cell defect in aryl hydrocarbon receptor deficient mice is associated with T cell hyperactivation during intestinal infection. PLoS ONE 2015, 10:e0128335.
114. Shih V.F., et al. Homeostatic IL-23 receptor signaling limits Th17 response through IL-22-mediated containment of commensal microbiota. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:13942-13947.
115. Stange J., Veldhoen M. The aryl hydrocarbon receptor in innate T cell immunity. Semin. Immunopathol. 2013, 35:645-655.
116. Sutton C.E., et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009, 31:331-341.
117. Kadow S., et al. Aryl hydrocarbon receptor is critical for homeostasis of invariant gammadelta T cells in the murine epidermis. J. Immunol. 2011, 187:3104-3110.
118. Narayan K., et al. Intrathymic programming of effector fates in three molecularly distinct gammadelta T cell subtypes. Nat. Immunol. 2012, 13:511-518.
119. Martin B., et al. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
120. Hahn M.E., et al. Molecular evolution of two vertebrate aryl hydrocarbon (dioxin) receptors (AHR1 and AHR2) and the PAS family. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:13743-13748.
121. Manchester D.K., et al. Ah receptor in human placenta: stabilization by molybdate and characterization of binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin, 3-methylcholanthrene, and benzo(a)pyrene. Cancer Res. 1987, 47:4861-4868.
122. Flaveny C., et al. The mouse and human Ah receptor differ in recognition of LXXLL motifs. Arch. Biochem. Biophys. 2008, 471:215-223.
123. Flaveny C.A., et al. Differential gene regulation by the human and mouse aryl hydrocarbon receptor. Toxicol. Sci. 2010, 114:217-225.
124. Forgacs A.L., et al. Comparative analysis of temporal and dose-dependent TCDD-elicited gene expression in human, mouse, and rat primary hepatocytes. Toxicol. Sci. 2013, 133:54-66.
125. Black M.B., et al. Cross-species comparisons of transcriptomic alterations in human and rat primary hepatocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 2012, 127:199-215.
126. 125I]iodo-7,8-dibromodibenzo-p-dioxin as a probe to determine the relative ligand affinity of human versus mouse aryl hydrocarbon receptor in cultured cells. Mol. Pharmacol. 2004, 66:129-136.
127. Schroeder J.C., et al. The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry 2010, 49:393-400.
128. Flaveny C.A., et al. Ligand selectivity and gene regulation by the human aryl hydrocarbon receptor in transgenic mice. Mol. Pharmacol. 2009, 75:1412-1420.
129. Shimada T., Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 2004, 95:1-6.